Laobaixing Pharmacy (603883) - Total Liabilities

Latest as of March 2026: CN¥12.61 Billion CNY ≈ $1.85 Billion USD

Based on the latest financial reports, Laobaixing Pharmacy (603883) has total liabilities worth CN¥12.61 Billion CNY (≈ $1.85 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 603883 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Laobaixing Pharmacy - Total Liabilities Trend (2011–2025)

This chart illustrates how Laobaixing Pharmacy's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Laobaixing Pharmacy total assets.

Laobaixing Pharmacy Competitors by Total Liabilities

The table below lists competitors of Laobaixing Pharmacy ranked by their total liabilities.

Company Country Total Liabilities
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
USA $27.10 Million
Sundaram Finance Holdings Limited
NSE:SUNDARMHLD
India Rs6.44 Billion
Bolsas y Mercados Argentinos SA
BA:BYMA
Argentina AR$2.01 Trillion
Longshine Technology Co Ltd
SHE:300682
China CN¥2.34 Billion
Hangzhou DPtech Technologies Co Ltd
SHE:300768
China CN¥473.17 Million
Playa Hotels & Resorts BV
F:PL0
Germany €1.33 Billion
Wuxi Shangji Automation Co Ltd
SHG:603185
China CN¥15.15 Billion
Hubei Jianghan New Materials Co. Ltd. A
SHG:603281
China CN¥351.43 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Laobaixing Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Laobaixing Pharmacy to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.90 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.85 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Laobaixing Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Laobaixing Pharmacy (2011–2025)

The table below shows the annual total liabilities of Laobaixing Pharmacy from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥12.85 Billion
≈ $1.88 Billion
-14.27%
2024-12-31 CN¥14.99 Billion
≈ $2.19 Billion
+7.51%
2023-12-31 CN¥13.94 Billion
≈ $2.04 Billion
-2.50%
2022-12-31 CN¥14.30 Billion
≈ $2.09 Billion
+17.41%
2021-12-31 CN¥12.18 Billion
≈ $1.78 Billion
+87.99%
2020-12-31 CN¥6.48 Billion
≈ $948.04 Million
+7.09%
2019-12-31 CN¥6.05 Billion
≈ $885.24 Million
+18.26%
2018-12-31 CN¥5.12 Billion
≈ $748.55 Million
+42.18%
2017-12-31 CN¥3.60 Billion
≈ $526.47 Million
+21.37%
2016-12-31 CN¥2.96 Billion
≈ $433.78 Million
+96.50%
2015-12-31 CN¥1.51 Billion
≈ $220.75 Million
+4.47%
2014-12-31 CN¥1.44 Billion
≈ $211.31 Million
+14.31%
2013-12-31 CN¥1.26 Billion
≈ $184.85 Million
+43.11%
2012-12-31 CN¥882.72 Million
≈ $129.17 Million
-3.30%
2011-12-31 CN¥912.83 Million
≈ $133.58 Million
--

About Laobaixing Pharmacy

SHG:603883 China Pharmaceutical Retailers
Market Cap
$1.44 Billion
CN¥9.82 Billion CNY
Market Cap Rank
#7476 Global
#1650 in China
Share Price
CN¥12.94
Change (1 day)
+0.47%
52-Week Range
CN¥10.96 - CN¥17.57
All Time High
CN¥331.82
About

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more